Indivior Pharmaceuticals, Inc. INDV Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $89M+89.4% | $102M+386% | $42M+90.9% | $18M+119% | $47M-23.0% | ||
| $2M-33.3% | $2M-60.0% | $3M-25.0% | $2M0.0% | $3M-40.0% | ||
| $9M+50.0% | $5M-16.7% | $7M+16.7% | $8M+33.3% | $6M0.0% | ||
| -$9M-112% | -$221M— | -$39M-2,050% | $158M+79.5% | $75M+303% | ||
| $20M+300% | $24M+50.0% | $20M+186% | $17M+325% | $5M+150% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$19M-280% | -$24M-400% | -$20M-157% | -$17M-1,800% | -$5M-120% | ||
| $126M+1,045% | —— | —— | —— | $11M-69.4% | ||
| $489M— | —— | —— | —— | $0-100% | ||
| $333M+8,225% | $5M-97.9% | $4M+300% | $4M— | $4M+300% | ||
| $7M+141% | -$5M— | -$3M+94.1% | -$5M+85.7% | -$17M+69.6% | ||
| -$20M-138% | -$252M-913% | -$61M-336% | $136M+152% | $53M+178% | ||
| -$29M-141% | -$245M— | -$59M— | $141M+67.9% | $70M+279% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Indivior Pharmaceuticals, Inc. generate?
- Indivior Pharmaceuticals, Inc. (INDV) generated -$111.0M in operating cash flow over the trailing twelve months.
- What is Indivior Pharmaceuticals, Inc. 's free cash flow?
- After $81.0M of capital expenditures, Indivior Pharmaceuticals, Inc. 's free cash flow was -$192.0M over the trailing twelve months, down 605.3% year over year.
- Where does Indivior Pharmaceuticals, Inc. 's cash flow data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
